0001437749-26-014678
SEC filingThis 10-K/A amendment completes the original filing by furnishing Part III governance disclosures on directors, executives, ownership, and auditors, ensuring full transparency without altering prior financials and reinforcing pay-performance alignment.
This Form 10-K/A (Amendment No. 1) addresses the original filing's placeholder for Part III by directly including director biographies, executive compensation structures, ownership details, and related disclosures, avoiding reliance on a proxy statement since none was anticipated by the May 4, 2026 filing date. Investors benefit from comprehensive transparency into leadership without any financial restatements, as the explanatory note confirms all prior metrics remain unchanged. This approach streamlines access to critical governance information, enabling better assessment of board oversight and incentive alignment amid RCM's focus on specialty engineering, IT, and healthcare services.
Bradley Vizi, serving as Executive Chairman since 2018, leverages his roots in activist investing at Legion Partners and Shamrock to enhance capital allocation—key for sustaining RCM's growth in high-demand engineering and IT services. His experience complements a board featuring Chigozie Amadi's prior CFO tenure at Siegel Group and deep audit background, ensuring robust financial stewardship. Swarna Kakodkar contributes tech leadership from Meta and Google, while Jayanth Komarneni brings McKinsey strategy and healthtech founding expertise. This diverse mix equips RCM to tackle sector-specific challenges, particularly in healthcare services led by Michael Saks and complex tech deployments, fostering innovation and operational resilience.
Executive compensation structures emphasize performance linkage, with severance terms for Vizi offering a 2.99x multiple of pay upon change-in-control. This design protects shareholder value by tying retention to strategic continuity during transitions. The independent board majority, supported by expert-led committees on strategy, risk, and compensation, oversees these arrangements to maintain governance standards. Such alignment incentivizes leadership to pursue sustainable growth in RCM's core markets, balancing short-term execution with long-term value creation.
The disclosures outline policies that mitigate key risks, including robust committee oversight and performance-based incentives. By finalizing Part III directly in this amendment, RCM demonstrates commitment to timely, complete reporting, reducing uncertainty for investors evaluating board effectiveness and executive accountability. This governance framework supports RCM's positioning in competitive tech and healthcare services, where leadership depth directly influences client acquisition and service delivery.